Thoroughbred Financial Services LLC Acquires Shares of 1,253 Axon Enterprise, Inc. (NASDAQ:AXON)

Thoroughbred Financial Services LLC bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,253 shares of the biotechnology company’s stock, valued at approximately $368,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. ICA Group Wealth Management LLC bought a new position in Axon Enterprise during the 4th quarter valued at $26,000. Blue Trust Inc. raised its holdings in shares of Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after purchasing an additional 79 shares during the last quarter. Trivant Custom Portfolio Group LLC purchased a new position in Axon Enterprise during the first quarter worth about $31,000. First PREMIER Bank bought a new stake in Axon Enterprise in the 1st quarter worth about $33,000. Finally, Blue Bell Private Wealth Management LLC purchased a new stake in Axon Enterprise in the 1st quarter valued at about $41,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In related news, CEO Patrick W. Smith sold 80,300 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares in the company, valued at $1,121,052,771.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $373.03, for a total transaction of $167,863.50. Following the completion of the sale, the director now owns 7,379 shares of the company’s stock, valued at $2,752,588.37. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the transaction, the chief executive officer now owns 3,015,366 shares in the company, valued at $1,121,052,771.48. The disclosure for this sale can be found here. Insiders have sold a total of 316,981 shares of company stock valued at $115,281,744 in the last 90 days. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Up 1.6 %

Shares of Axon Enterprise stock opened at $385.77 on Tuesday. The company’s 50-day moving average price is $340.58 and its 200-day moving average price is $315.24. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a 12-month low of $189.12 and a 12-month high of $386.54. The company has a market cap of $29.15 billion, a price-to-earnings ratio of 112.80, a PEG ratio of 10.30 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The firm had revenue of $504.00 million during the quarter, compared to analyst estimates of $478.35 million. During the same period in the previous year, the business earned $0.80 EPS. The business’s revenue for the quarter was up 34.5% on a year-over-year basis. On average, equities analysts expect that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Analyst Ratings Changes

AXON has been the subject of a number of research analyst reports. Robert W. Baird increased their price target on Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a research report on Tuesday, September 10th. Needham & Company LLC restated a “buy” rating and set a $400.00 price target on shares of Axon Enterprise in a research report on Wednesday, August 7th. Bank of America started coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They issued a “buy” rating and a $380.00 target price on the stock. Craig Hallum lifted their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Finally, JMP Securities increased their price objective on Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, September 12th. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $365.38.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.